|
Hematology/ Hematologic Malignancies
Contributing journals to this collection:
JAMA & Archives Journals
Citations 571-580 of 693 total displayed.
- Editorials
A New Rexinoid for Cutaneous T-Cell Lymphoma
- Sola X. Cheng; Thomas Kupper
Arch Dermatol 2001; 137: 649-652.
[Extract]
[Full text]
[PDF]
- Review Articles
An Update on Hypercoagulable Disorders
- Daniel G. Federman; Robert S. Kirsner
Arch Intern Med 2001; 161: 1051-1056.
[Abstract]
[Full text]
[PDF]
- Grand Rounds
HIV-Associated Non-Hodgkin Lymphoma: Incidence, Presentation, and Prognosis
- Richard F. Little; Martin Gutierrez; Elaine S. Jaffe; Alice Pau; McDonald Horne; Wyndham Wilson
JAMA 2001; 285: 1880-1885.
[Abstract]
[Full text]
[PDF]
- JAMA Patient Page
Lymphoma
-
JAMA 2001; 285: 1920.
[PDF]
[ Key Words ]
- Original Contributions
Association of Cancer With AIDS-Related Immunosuppression in Adults
- Morten Frisch; Robert J. Biggar; Eric A. Engels; James J. Goedert; for the AIDS-Cancer Match Registry Study Group
JAMA 2001; 285: 1736-1745.
[Abstract]
[Full text]
[PDF]
- Studies
Clinicopathologic, Immunophenotypic, and Molecular Characterization of Primary Cutaneous Follicular B-Cell Lymphoma
- Reuven Bergman; Paul J. Kurtin; Lawrence E. Gibson; Peter R. Hull; Teresa K. Kimlinger; Arnold L. Schroeter
Arch Dermatol 2001; 137: 432-439.
[Abstract]
[Full text]
[PDF]
- Observations
Cutaneous Adverse Reactions to Hydroxyurea in Patients With Sickle Cell Disease
- Bénédicte Chaine; Maria-Grazia Neonato; Robert Girot; Sélim Aractingi
Arch Dermatol 2001; 137: 467-470.
[Abstract]
[Full text]
[PDF]
- Editorials
Primary Cutaneous Follicular Lymphoma
- Lorenzo Cerroni; Helmut Kerl
Arch Dermatol 2001; 137: 489-490.
[Extract]
[Full text]
[PDF]
- Articles
Intravenous Ketorolac in the Emergency Department Management of Sickle Cell Pain and Predictors of Its Effectiveness
- James L. Beiter Jr; Harold K. Simon; C. Robert Chambliss; Thomas Adamkiewicz; Kevin Sullivan
Arch Pediatr Adolesc Med 2001; 155: 496-500.
[Abstract]
[Full text]
[PDF]
- Neurotherapeutics
Stroke Prevention and Treatment in Sickle Cell Disease
- Robert J. Adams
Arch Neurol 2001; 58: 565-568.
[Extract]
[Full text]
[PDF]
|
Advertisement


|
|
|